Evidence map›Paper›PMID 24532998›Full record

ArticleJournal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine2014

Obstructive sleep apnea and fatigue in patients with multiple sclerosis.

Tiffany J Braley, Benjamin M Segal, Ronald D Chervin

2 registry-linked trialsOpen access · bronzeAbstract read
In one paragraph

Article in Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 50 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 3 pooled it
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02544373 nacompletednot on this mapstarted 2015, after this paper: background citation

A Randomized Trial of Positive Airway Pressure Therapy to Treat Cognitive Dysfunction in MS Patients With Obstructive Sleep Apnea

TypeinterventionalSponsorUniversity of MichiganRan2015 to 2021Enrolled135ConditionsMultiple SclerosisArmsPAP therapy
NCT03949296 nacompletednot on this mapstarted 2017, after this paper: background citation

A Randomized, Placebo-Controlled Study of Mindfulness Meditation in Treating Insomnia in Multiple Sclerosis

TypeinterventionalSponsorGriffin HospitalRan2017 to 2019Enrolled49ConditionsInsomnia Chronic, Multiple SclerosisArmsMindfulness Intervention, Sleep Hygiene
3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 3 syntheses or guidelines pooled it, 108 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Sleep and neuroimmunology: a narrative review.Encephalitis (Seoul, Korea) · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Sleep Disturbances, Degree of Disability and the Quality of Life in Multiple Sclerosis Patients.International journal of environmental research and public health · 2022
    Article
  17. Article
  18. Review
  19. Article
  20. A multidimensional approach to sleep health in multiple sclerosis.Multiple sclerosis and related disorders · 2021
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Tiffany J BraleyUniversity of Michigan Department of Neurology and Multiple Sclerosis Center, Ann Arbor, MI ; University of Michigan Department of Neurology and Sleep Disorders Center, Ann Arbor, MI.
Benjamin M SegalUniversity of Michigan Department of Neurology and Multiple Sclerosis Center, Ann Arbor, MI.
Ronald D ChervinUniversity of Michigan Department of Neurology and Sleep Disorders Center, Ann Arbor, MI.
University of Michigan · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

STUDY

objectivesThe prevalence of obstructive sleep apnea (OSA) in persons with multiple sclerosis (MS) remains unknown, and little information exists regarding the relative contributions of OSA to symptoms of MS-related fatigue in the presence of other clinical and sleep-related confounders. The objectives of this study were to investigate the prevalence of diagnosed OSA and OSA risk among MS patients, and to assess relationships between fatigue severity, OSA, OSA risk, and sleep quality among persons with MS.

methodsN = 195 MS patients completed a questionnaire comprised of items regarding OSA diagnosis, sleep quality and quantity, daytime symptoms, and 4 validated scales: the Epworth Sleepiness Scale, Fatigue Severity Scale, Insomnia Severity Index, and STOP-Bang questionnaire. Medical records were also accessed to examine clinical characteristics that may predict fatigue or OSA risk.

resultsN = 41 patients (21%) carried a formal diagnosis of OSA. N = 110 (56%) of all patients, and 38 (93%) of those with diagnosed OSA had STOP-Bang scores ≥ 3, indicating an elevated OSA risk. In regression models, the most significant predictors of higher FSS scores were higher STOP-Bang scores (p = 0.01), higher number of nocturnal symptoms (p < 0.0001), and higher disability level (p < 0.0001).

conclusionsSleep disturbances, and OSA in particular, may be highly prevalent yet underrecognized contributors to fatigue in persons with MS.

Indexed as

ComorbidityFatigueFemaleHumansMaleMiddle AgedMultiple SclerosisPolysomnographyPrevalenceRiskSeverity of Illness IndexSleep Apnea, ObstructiveSurveys and QuestionnairesUnited Statesfatiguemultiple sclerosisobstructive sleep apneasleep disturbanceSTOP-Bang

Identifiers

PMID24532998
PMCPMC3899317
OpenAlexW1983379291

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.